Our US Pharmaceuticals portfolio includes key marketed products, many of which are leaders in their respective therapeutic areas. Since 2000, our US division has received the most approvals of any pharmaceutical company in the industry.
Key pharmaceutical products marketed by Novartis in the US are listed below by therapeutic area, brand name and generic name.
Important Information:
Disease categories and product names are listed for your convenience in searching for and finding information about Novartis offerings. They are not intended to provide complete medical or product information. SHOULD YOU HAVE A MEDICAL CONDITION, PROMPTLY SEE YOUR OWN MEDICAL DOCTOR OR HEALTHCARE PROVIDER. Please see important safety information in the complete Prescribing Information, available by clicking on highlighted links near product names.
by generic name
Acetylcholine Chloride
Aldesleukin
Aliskiren
Aliskiren and Hydrochlorothiazide
Amlodipine Besylate and Benazepril Hydrochloride
Amlodipine and Valsartan
Amlodipine, Valsartan, and Hydrochlorothiozide
Artemether/Lumefantrine
Basiliximab
Benazepril Hydrochloride
Benazepril Hydrochloride and Hydrochlorothiazide Usp
Bromocriptine Mesylate
Calcitonin-Salmon (injection)
Calcitonin-Salmon (nasal spray)
Canakinumab
Carbamazepine (extended-release tablets)
Carbamazepine (tablets, chewable tablets, suspension)
Carbidopa, Levodopa and Entacapone
Clozapine
Cyclosporine
Cyclosporine
Deferasirox
Deferoxamine Mesylate
Derifenacin
Dexmethylphenidate Hydrochloride (tablets)
Dexmethylphenidate Hydrochloride (extended-release capsules)
Diclofenac Potassium
Diclofenac Sodium (enteric-coated tablets)
Diclofenac Sodium (extended-release tablets)
Diclofenac Sodium (ophthalmic solution 0.1%)
Entacapone
Estradiol
Estradiol
Estradiol
Estradiol/Norethindrone Acetate
Everolimus
Famciclovir
Fluvastatin Sodium
Fluvastatin Sodium Extended-Release
Imatinib Mesylate
Letrozole
Methylergonovine Maleate
Methylergonovine Maleate
Methylphenidate Hydrochloride
Methylphenidate Hydrochloride Extended-Release
Methylphenidate Hydrochloride Sustained-Release
Metoprolol Tartrate
Metoprolol Tartrate Usp and Hydrochlorothiazide Usp
Mycophenolic Acid
Nateglinide
Nilotinib
Octreotide Acetate
Octreotide Acetate
Omalizumab
Oxcarbazepine
Pamidronate Disodium
Pimecrolimus
Rivastigmine
Rivastigmine Tartrate
Tegaserod Maleate
Telbivudine
Terbinafine Hydrochloride (tablets)
Terbinafine Hydrochloride (oral granules)
Tobramycin
Valsartan
Valsartan and Hydrochlorothiazide Combination
Verteporfin
Zoledronic Acid
Zoledronic Acid
DISEASES & CONDITIONS
Knowing more about different diseases and conditions makes it easier for you to take a more active role in keeping you and your family healthy.
ACCESS TO MEDICINES
Novartis puts patients first. We want to create value for all patients, including those who cannot afford treatment. That is why we established Patient Assistance Now, a resource that allows you to access programs that may help you pay for your Novartis medicines.
PATIENT ASSISTANCE PROGRAMS
Through our Patient Assistance Programs, we are committed to providing access to our medications for those most in need.